COCP
Cocrystal Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.19
+4.39%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.15
- Revenue estimate
- $105.0K
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.23
- EPS estimate
- -$0.17
- Revenue actual
- $105.0K
- Revenue estimate
- $105.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -6.7%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.17 | -$0.23 | Miss -39.39% | $105.0K |
| May 21, 2026 | -$0.15 | -$0.16 | Miss -6.67% | — |
| Mar 31, 2026 | -$0.18 | -$0.17 | Beat 5.56% | — |
| Nov 14, 2025 | -$0.22 | -$0.19 | Beat 13.64% | — |
| Aug 14, 2025 | -$0.30 | -$0.20 | Beat 33.33% | — |
| May 15, 2025 | -$0.52 | -$0.23 | Beat 55.77% | — |
| Mar 31, 2025 | -$0.55 | -$0.32 | Beat 41.82% | $136.0K |
| Nov 13, 2024 | -$0.57 | -$0.49 | Beat 14.04% | — |
| Aug 14, 2024 | -$0.51 | -$0.53 | Miss -3.92% | — |
| Nov 13, 2023 | -$0.47 | -$0.41 | Beat 12.77% | — |
| Aug 14, 2023 | -$0.53 | -$0.50 | Beat 5.66% | — |
| May 15, 2023 | -$0.59 | -$0.64 | Miss -8.47% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026